Graf Akcie ABMD (Abiomed Inc.). Diskuze k akciím ABMD. Aktuální informace ABMD.

Základní informace o společnosti Abiomed Inc. (Akcie ABMD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 15.3B
Hodnota podniku (EV) 15.13B
Tržby 935.257M
EBITDA 287.22M
Zisk 154.412M
Růst v tržbách Q/Q 53.22 %
Růst v tržbách Y/Y 17.19 %
P/E (Cena vůči ziskům) 102.74
Forward P/E 6.01
EV/Sales 16.18
EV/EBITDA 52.69
EV/EBIT 69.48
PEG 1.33
Price/Sales 16.36
P/FCF 61.78
Price/Book 11.51
Účetní hodnota na akcii 30.53
Hotovost na akcii 13.40
FCF vůči ceně 1.62 %
Počet zaměstnanců 1,725
Tržba na zaměstnance 542.178k
Profit margin 26.61 %
Operating margin 15.63 %
Gross margin 80.90 %
EBIT margin 23.29 %
EBITDA margin 30.71 %
EPS - Zisk na akcii 3.42
EPS - Kvartální růst 12.24 %
EPS - Očekávaný růst příští rok -28.68 %
Return on assets 10.82 %
Return on equity 12.16 %
ROIC 21.26 %
ROCE 16.19 %
Dluhy/Equity 0.12
Čistý dluh/EBITDA -7.40
Current ratio 6.45
Quick Ratio 5.71
Volatilita 2.66
Beta 0.87
RSI 58.01
Cílová cena analytiků 312
Známka akcie (dle analytiků) N/A
Insider ownership 2.05 %
Institutional ownership 93.43 %
Počet akcií 45.38M
Procento shortovaných akcií 1.96 %
Short ratio 4.27 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1987
Země United States

Finanční výsledky akcie ABMD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$840.883$769.432$593.749$445.304$329.543$230.311
Cost Of Goods Sold$151.305$129.567$98.581$70.627$50.419$39.945
Gross Profit$689.578$639.865$495.168$374.677$279.124$190.366
Research And Development Expenses$98.759$93.503$75.297$66.386$49.759$35.973
SG&A Expenses$341.6$321.55$262.734$218.153$164.261$125.727
Other Operating Income Or Expenses------
Operating Expenses$591.664$544.62$436.612$355.166$264.439$201.645
Operating Income$249.219$224.812$157.137$90.138$65.104$28.666
Total Non-Operating Income/Expense$7.606$38.548$3.3$1.205$0.734$0.099
Pre-Tax Income$256.825$263.36$160.437$91.343$65.838$28.765
Income Taxes$53.816$4.344$48.267$39.227$27.691$-84.923
Income After Taxes$203.009$259.016$112.17$52.116$38.147$113.688
Other Income------
Income From Continuous Operations$203.009$259.016$112.17$52.116$38.147$113.688
Income From Discontinued Operations------
Net Income$203.009$259.016$112.17$52.116$38.147$113.688
EBITDA$269.649$238.933$168.142$96.34$68.381$31.436
EBIT$249.219$224.812$157.137$90.138$65.104$28.666
Basic Shares Outstanding454544434241
Shares Outstanding464646454543
Basic EPS$4.49$5.77$2.54$1.21$0.90$2.80
EPS - Earnings Per Share$4.43$5.61$2.45$1.17$0.85$2.65
# 2020 2019 2018 2017 2016 2015
Current Ratio4.82136.38885.83684.69656.19654.7061
Long-term Debt / Capital---0.0332--
Debt/Equity Ratio---0.0361--
Gross Margin82.006483.160783.396984.139684.700382.6561
Operating Margin29.637829.217926.465220.241919.755812.4467
EBIT Margin29.637829.217926.465220.241919.755812.4467
EBITDA Margin32.067431.053228.318721.634720.750313.6494
Pre-Tax Profit Margin30.542334.227827.02120.512519.978612.4896
Net Profit Margin24.142433.663318.891811.703511.575749.3628
Asset Turnover0.69130.72980.7550.8090.77740.6807
Inventory Turnover Ratio1.67951.60071.96362.02191.88552.3814
Receiveable Turnover9.93368.47318.48098.2387.69587.2361
Days Sales In Receivables36.743843.077643.037844.30747.428350.4414
ROE - Return On Equity19.053527.646416.267711.528310.344338.993
Return On Tangible Equity19.642928.643117.158812.378311.36143.7218
ROA - Return On Assets16.688524.566514.26429.46858.998433.599
ROI - Return On Investment19.053527.646416.267711.145210.344338.993
Book Value Per Share23.672320.76315.538610.35138.65757.0534
Operating Cash Flow Per Share1.4091.2651.62190.86720.70040.4461
Free Cash Flow Per Share1.4021.52991.53240.08630.47350.3914